Figure 2.
CDR3-size spectratype analysis of CD4+ T cells enriched from PBMC of three patients after receiving LLME treated DLI. The spectratype analysis was performed as described in “Materials and Methods.” A representative Vβ spectratype is shown for each patient comparing the LLME-treated DLI to the reconstituting patient repertoire, post-transplant.
